Neural correlates of delusional infestation responding to aripiprazole monotherapy: a case report

QR Code

Neural correlates of delusional infestation responding to aripiprazole monotherapy: a case report

Laura Ponson,1,2 Frédéric Andersson,1 Wissam El-Hage1,2 1Université François-Rabelais de Tours, Inserm, Imagerie et Cerveau UMR U930, Tours, France, 2CHRU de Tours, Clinique Psychiatrique Universitaire, Tours, France Background: The pathophysiology and...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ponson L, Andersson F, El-Hage W
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2015
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/53dc66a9647848dea1a1bcc0abdaa91f
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Severe water intoxication and secondary depressive syndrome in relation to delusional infestation
par: Lai J, et autres
Publié: (2016)

Quetiapine monotherapy for bipolar depression
par: Michael E Thase
Publié: (2008)

Role of aripiprazole in treatment-resistant schizophrenia
par: Mossaheb N, et autres
Publié: (2012)

Worsened hypertension control induced by aripiprazole
par: Yasui-Furukori N, et autres
Publié: (2013)

Monotherapy for partial epilepsy: focus on levetiracetam
par: Antonio Gambardella, et autres
Publié: (2008)

Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
par: Izchak Kohen, et autres
Publié: (2010)

Aripiprazole: from pharmacological profile to clinical use
par: Di Sciascio G, et autres
Publié: (2015)

Aripiprazole-associated tic in a schizophrenia patient
par: Guo X, et autres
Publié: (2015)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
par: Ranjbar F, et autres
Publié: (2015)

Augmentation treatment in major depressive disorder: focus on aripiprazole
par: J Craig Nelson, et autres
Publié: (2008)

Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
par: Jason T Lerner, et autres
Publié: (2010)

Combination therapy or monotherapy for the depressed type of schizoaffective disorder
par: Lubomira Iz&aacute;kov&aacute;, et autres
Publié: (2009)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
par: Pecenak J, et autres
Publié: (2013)

Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
par: Wang SM, et autres
Publié: (2014)

Aripiprazole in the treatment of Huntington&rsquo;s disease: a case series
par: Andrea Ciammola, et autres
Publié: (2008)

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
par: McIntyre R, et autres
Publié: (2011)

Treatment and prevention of mania in bipolar&nbsp;I disorder: focus on aripiprazole
par: David J Muzina
Publié: (2009)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
par: Pecenak J, et autres
Publié: (2013)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
par: Delia Bishara, et autres
Publié: (2009)

Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis
par: De Hert M, et autres
Publié: (2015)

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
par: Kishi T, et autres
Publié: (2015)

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
par: Berman R, et autres
Publié: (2011)

Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study
par: Hsu YC, et autres
Publié: (2015)

Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
par: Oya K, et autres
Publié: (2015)

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
par: Takahashi M, et autres
Publié: (2012)

An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia
par: Giorgio L Colombo, et autres
Publié: (2008)

Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
par: Zhi P, et autres
Publié: (2018)

A systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazole
par: Salvatore Gentile
Publié: (2009)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study
par: Wani RA, et autres
Publié: (2015)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
par: Wani RA, et autres
Publié: (2015)

Emerging treatments in the management of bipolar disorder &ndash; focus on risperidone long acting injection
par: Wissam El-Hage, et autres
Publié: (2010)

Olanzapine–valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group
par: Xu L, et autres
Publié: (2015)

Not all partial dopamine D2 receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse
par: Athan Spiros, et autres
Publié: (2010)

Erratum:&nbsp;An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967&ndash;976
par: Colombo GL, et autres
Publié: (2009)

Severe arrhythmia induced by orally disintegrating aripiprazole tablets (Bosiqing®): a case report
par: Shao Q, et autres
Publié: (2015)

Low-dose aripiprazole for refractory burning mouth syndrome
par: Umezaki Y, et autres
Publié: (2016)

Adult neural stem cells: The promise of the future
par: Philippe Taupin
Publié: (2007)

Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
par: Franziska Albrecht, et autres
Publié: (2017)

Aripiprazole for the treatment of psychotic symptoms in patients with dementia with Lewy bodies: a case series
par: Sugawara Kikuchi Y, et autres
Publié: (2019)

Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies
par: Madera JJ, et autres
Publié: (2019)